[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 113,587,888
  • Shares Outstanding, K 253,805
  • Annual Sales, $ 12,001 M
  • Annual Income, $ 3,953 M
  • EBIT $ 4,681 M
  • EBITDA $ 4,891 M
  • 60-Month Beta 0.30
  • Price/Sales 9.47
  • Price/Cash Flow 25.49
  • Price/Book 5.89

Options Overview Details

View History
  • Implied Volatility 27.47% (+0.66%)
  • Historical Volatility 19.29%
  • IV Percentile 37%
  • IV Rank 22.33%
  • IV High 46.24% on 02/12/26
  • IV Low 22.08% on 08/27/25
  • Expected Move (DTE 6) 14.32 (3.20%)
  • Put/Call Vol Ratio 1.73
  • Today's Volume 2,555
  • Volume Avg (30-Day) 2,592
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 51,935
  • Open Int (30-Day) 48,969
  • Expected Range 433.22 to 461.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 34 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $4.19
  • Number of Estimates 7
  • High Estimate $4.47
  • Low Estimate $3.79
  • Prior Year $4.00
  • Growth Rate Est. (year over year) +4.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
412.27 +8.56%
on 05/05/26
456.68 -2.00%
on 05/14/26
+24.30 (+5.74%)
since 04/29/26
3-Month
412.27 +8.56%
on 05/05/26
507.92 -11.89%
on 03/10/26
-49.29 (-9.92%)
since 02/27/26
52-Week
362.50 +23.46%
on 08/11/25
507.92 -11.89%
on 03/10/26
+2.44 (+0.55%)
since 05/28/25

Most Recent Stories

More News
2 Healthcare Stocks with Exciting Potential and 1 Facing Challenges

2 Healthcare Stocks with Exciting Potential and 1 Facing Challenges

COO : 61.21 (+0.28%)
VRTX : 447.54 (-0.10%)
CLOV : 3.98 (-4.78%)
What Are Wall Street Analysts' Target Price for Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

$SPX : 7,580.06 (+0.22%)
JPM : 299.31 (+0.87%)
VRTX : 447.54 (-0.10%)
BBH : 188.64 (+0.19%)
Vertex to Participate in Upcoming May Investor Conferences

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences. Charlie Wagner, Chief Operating and...

VRTX : 447.54 (-0.10%)
5 Must-Read Analyst Questions From Vertex Pharmaceuticals’s Q1 Earnings Call

5 Must-Read Analyst Questions From Vertex Pharmaceuticals’s Q1 Earnings Call

VRTX : 447.54 (-0.10%)
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany

-The agreement ensures sustainable access to this innovative therapy for eligible patients ages 12 years and older in Germany-

VRTX : 447.54 (-0.10%)
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q1 CY2026 Sales Expectations

Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q1 CY2026 Sales Expectations

VRTX : 447.54 (-0.10%)
Vertex: Q1 Earnings Snapshot

Vertex: Q1 Earnings Snapshot

VRTX : 447.54 (-0.10%)
Vertex Reports First Quarter 2026 Financial Results

– Total revenue of $2.99 billion, an 8% increase compared to first quarter 2025 – – Povetacicept program continues rapid advancement: Completed rolling...

VRTX : 447.54 (-0.10%)
Jobs Figures Roll in Friday in Canada

Monday U.S. Featured Earnings Palantir Technologies Inc. (NASDAQ: PLTR) (Q1) EPS ...

ANET : 159.47 (+2.70%)
NVO : 45.58 (+0.15%)
VRTX : 447.54 (-0.10%)
SATS : 129.19 (-1.43%)
WMB : 71.39 (-2.38%)
HSBC : 93.74 (+0.85%)
DIS : 101.83 (-1.83%)
MCD : 279.20 (+0.44%)
PAA : 22.43 (-1.62%)
UI : 583.86 (-1.87%)
AMD : 516.10 (-0.38%)
SHEL : 84.12 (+0.35%)
Vertex's Non-CF Portfolio Finally Gets Its Credibility Test Monday

Barchart Research What to Expect from VRTX Earnings VRTX Generated May 1, 2026 Current Price $423.92 EPS Estimate $$3.67 Consensus Rating Moderate Buy Average Move 6.30% Vertex's Non-CF Portfolio Finally...

VRTX : 447.54 (-0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 458.69
2nd Resistance Point 454.35
1st Resistance Point 450.94
Last Price 447.54
1st Support Level 443.19
2nd Support Level 438.85
3rd Support Level 435.44

See More

52-Week High 507.92
Fibonacci 61.8% 452.37
Last Price 447.54
Fibonacci 50% 435.21
Fibonacci 38.2% 418.05
52-Week Low 362.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.